Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Taxes (2016 - 2017)

Amphastar Pharmaceuticals (AMPH) has 5 years of Change in Taxes data on record, last reported at -$2.5 million in Q3 2017.

  • For Q3 2017, Change in Taxes fell 351.29% year-over-year to -$2.5 million; the TTM value through Sep 2017 reached -$5.8 million, down 236.88%, while the annual FY2015 figure was -$92000.0, 116.46% down from the prior year.
  • Change in Taxes reached -$2.5 million in Q3 2017 per AMPH's latest filing, up from -$3.2 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $6.0 million in Q4 2014 and bottomed at -$5.4 million in Q3 2014.
  • Average Change in Taxes over 5 years is -$106687.5, with a median of -$133500.0 recorded in 2013.
  • The widest YoY moves for Change in Taxes: up 15137.5% in 2014, down 3857.35% in 2014.
  • A 5-year view of Change in Taxes shows it stood at -$40000.0 in 2013, then skyrocketed by 15137.5% to $6.0 million in 2014, then crashed by 83.52% to $991000.0 in 2015, then plummeted by 154.89% to -$544000.0 in 2016, then plummeted by 351.29% to -$2.5 million in 2017.
  • Per Business Quant database, its latest 3 readings for Change in Taxes were -$2.5 million in Q3 2017, -$3.2 million in Q2 2017, and $394000.0 in Q1 2017.